" "Zosano Pharma Corp (ZSAN) Receives Average Rating of " from Brokerages

The company saw 1.56 million shares trade hands over the course of the day. The stock gained a consensus recommendation of 2 on Zacks Investment Research where the scale runs from 1 to 5, 1 representing Strong buy and 5 showing Strong Sell. If you are investing like Buffett, the report can assist in finding the company with the durable competitive advantage, and if Peter Lynch is your hero, you might find a low P/E ratio, share buyback or future earnings growth in the depths of the report. However, the stock is trading at -51.96% versus recent highs ($3.54). The company maintains price to book ratio of 6.22 vs.an industry average at 10.15. The 1-year price target of the company is 3.25.

Zosano Pharma Corporation has 1 year price target of $3.25.

The highest price ZSAN stock touched in the last 12 month was $3.54 and the lowest price it hit in the same period was $0.45. Movements above 70 are interpreted as indicating overbought conditions; conversely, movements under 30 reflect oversold conditions.

Zosano Pharma Corporation (NASDAQ:ZSAN) traded at an unexpectedly low level on March 22, 2017 when the stock experienced a 4.94 gain to a closing price of $1.7.

Analysts mean Recommendation on a stock is noted at 2.00.

Investors expected a price target of -0.18 for this quarter.

Zosano Pharma Corporation (ZSAN) stock price distance from twenty day simple moving average slumped at -37.53% while its distance from fifty day simple moving average declined -10.68% along with 30.20% above distance from two hundred simple moving averages.

Zosano Pharma Corporation (NASDAQ:ZSAN) plummeted -9.88 percent and ended the day at $1.55.

While looking at the Stock's Performance, Zosano Pharma Corporation now shows a Weekly Performance of -34.04%, where Monthly Performance is -45.61%, Quarterly performance is 68.48%, 6 Months performance is 104.67% and yearly performance percentage is -41.95%. The company has a Return on Assets (ROA) of -100.20%.

While taking a glance at financials, we can look at a number of key indicators. Company net profit margin stands at 5.20% whereas its return on equity (ROE) is 259.70%.

Zosano Pharma Corporation (NASDAQ:ZSAN) performance during the last one year Degraded -41.95 percent, while its year to date (YTD) performance showed a Positive trend of 98.72 percent. 0 have given the stock a Hold rating, 0 as Underperform and 0 as Sell. The stock's average true range of stands at 0.37, while the relative strength index is 36.68.

In the liquidity ratio analysis; quick ratio for most recent quarter was 1.60 while current ratio for time period was 1.60.

  • Zachary Reyes